Clinical Trials on Relapsed or Refractory Lymphoproliferative Malignancies
Total 5414 results
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Qilu Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
ADC Therapeutics S.A.No longer availableRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
LaNova Medicines LimitedWithdrawnRelapsed or Refractory Multiple Myeloma | Other Plasma Cell Diseases
-
First Affiliated Hospital of Harbin Medical UniversityUnknownCD19-chimeric Antigen Receptor T Cells | Relapsed and/or Refractory Acute Lymphoblastic Leukemia | the Haploidentical Hematopoietic Stem Cell TransplantationChina
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
National Cancer Center, KoreaRecruitingRelapsed/Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Classical Hodgkin's LymphomaChina
-
University Hospital, BordeauxNovartis; National Cancer Institute, France; Fondation ARCRecruitingRefractory or Recurrent Solid TumorFrance
-
University of WashingtonRecruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Refractory Mantle Cell Lymphoma | Recurrent Follicular... and other conditionsUnited States
-
University of WashingtonAbbVieSuspendedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Mixed Phenotype Acute Leukemia | Myeloid Neoplasm | Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic Leukemia | Relapsed Acute Myeloid Leukemia | Mixed Phenotype Acute Leukemia | Relapsed Acute Biphenotypic Leukemia | Relapsed... and other conditionsUnited States
-
LLS PedAL Initiative, LLCKura OncologyNot yet recruitingRelapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
-
Sorrento Therapeutics, Inc.WithdrawnSolid Tumor, Adult | Refractory Cancer | Relapsed Solid Neoplasm
-
Shenzhen BinDeBio Ltd.Xiangya Hospital of Central South UniversityRecruitingRelapsed B-cell Acute Lymphoblastic Leukemia, Childhood | Refractory B-cell Acute Lymphoblastic Leukemia, Childhood | Relapsed/Refractory B-cell Lymphoma, ChildhoodChina
-
Memorial Sloan Kettering Cancer CenterCompletedHuman Papillomavirus (HPV)-Related Malignancies | Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesUnited States
-
Clavis PharmaSyneos Health; Theradex; CardiaBase; Learn & ConfirmCompletedRelapsed/Refractory AMLUnited Kingdom, Spain
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy
-
Shenzhen BinDeBio Ltd.Children's Hospital of Fudan UniversityActive, not recruitingRelapsed B-cell Acute Lymphoblastic Leukemia, Childhood | Refractory B-cell Acute Lymphoblastic Leukemia, Childhood | Relapsed/Refractory B-cell Lymphoma, ChildhoodChina
-
ImmunityBio, Inc.Not yet recruitingNon Hodgkin's Lymphoma Refractory/RelapsedUnited States
-
IGM Biosciences, Inc.No longer availableRelapsed/Refractory Non-Hodgkin LymphomasAustralia, Korea, Republic of, Spain
-
Regeneron PharmaceuticalsCompletedRelapsed/Refractory Follicular LymphomaAustria, France, Germany, United Kingdom
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
Samsung Medical CenterMinistry of Health, Republic of KoreaRecruitingRelapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Samsung Medical CenterMinistry of Health, Republic of KoreaNot yet recruitingRelapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Follicular LymphomaUnited States, Spain, United Kingdom, Italy, France, Japan, Germany
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownRelapsed / Refractory Follicular LymphomaChina
-
ADC Therapeutics S.A.CompletedRefractory Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States, Spain, United Kingdom, Poland, Belgium, Hungary, Germany, France, Italy, Czechia, Canada
-
University of UtahElevar TherapeuticsTerminatedUrothelial Carcinoma | Advanced Malignancies | Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | MSI-H or dMMR Solid TumorsUnited States
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
Cyclacel Pharmaceuticals, Inc.CompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States
-
AstraZenecaApproved for marketingRelapsed/Refractory Hairy Cell Leukemia
-
ImmunityBio, Inc.Not yet recruitingNon-Hodgkin Lymphoma Refractory/ Relapsed
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
University Health Network, TorontoRecruitingClassical Hodgkin Lymphoma | Relapsed Cancer | Refractory CancerCanada
-
Matthew J. Frigault, M.D.NovartisActive, not recruitingPrimary CNS Lymphoma | Refractory Primary CNS Lymphoma | Relapsed Primary CNS LymphomaUnited States
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
Merck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic LeukemiaUnited States, Israel, Spain
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Active, not recruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Plasma Cell Myeloma | Aplastic Anemia | Malignant Neoplasm | Myeloproliferative Neoplasm | Indolent Non-Hodgkin Lymphoma | Acute Myeloid Leukemia in Remission | Refractory Anemia | Refractory Anemia With... and other conditionsUnited States
-
TCRx Therapeutics Co.LtdRecruitingRefractory Solid Tumors | Relapsed Solid Tumors | TCR-T CellsChina
-
National Cancer Institute (NCI)RecruitingMultiple Myeloma | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Newly Diagnosed Multiple Myeloma (NDMM)United States